The bioprotectants market was estimated to be worth $5.5 billion in 2022, with this figure set to rise to over $11 billion by 2027. With more than 1000 products on the market, a greater understanding of how individual species/strains function as bioprotection agents is required.
Advances in bioprotection of plants against diseases considers recent advances in techniques used to identify and develop fungal and bacterial bioprotection agents, including Clonostachys rosea, Phytium oligandrum and Actinomycetes. The book also includes a variety of case studies which detail the successful implementation of bioprotection agents to control diseases in a variety of crops, including grapes, cereals and potatoes.
This book builds on and adds to the successful recent title published by Burleigh Dodds Science: Microbial bioprotectants for plant disease management (2021).
- Reviews the latest trends in the rapidly evolving bioprotectants sector
- Highlights the importance of developing an effective regulatory regime for bioprotectants
- Considers the range of techniques for identifying bioprotectants
